Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.
Kittelson, J M
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach. [electronic resource] - Journal of thrombosis and haemostasis : JTH Aug 2013 - 1443-8 p. digital
Publication Type: Journal Article; Review
1538-7836
10.1111/jth.12324 doi
Administration, Oral
Anticoagulants--therapeutic use
Hemorrhage--prevention & control
Humans
Morpholines--therapeutic use
Randomized Controlled Trials as Topic
Research Design
Risk
Rivaroxaban
Thiophenes--therapeutic use
Venous Thromboembolism--therapy
Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach. [electronic resource] - Journal of thrombosis and haemostasis : JTH Aug 2013 - 1443-8 p. digital
Publication Type: Journal Article; Review
1538-7836
10.1111/jth.12324 doi
Administration, Oral
Anticoagulants--therapeutic use
Hemorrhage--prevention & control
Humans
Morpholines--therapeutic use
Randomized Controlled Trials as Topic
Research Design
Risk
Rivaroxaban
Thiophenes--therapeutic use
Venous Thromboembolism--therapy